Association between tuberculosis treatment outcomes and the mobile antiretroviral therapy programme in Zambia

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 4, 2013, Pages 540-545

  Miyano, S ^a,b   Dube, C ^c   Kayama, N ^c   Ishikawa, N ^a,b   Nozaki, I ^a,b   Syakantu, G ^d  

^a JAPAN INTERNATIONAL COOPERATION AGENCY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c Mumbwa District Medical Office   (Zambia)

^d MINISTRY OF HEALTH   (Zambia)

Author keywords

HIV; Rural health centres; Tuberculosis; Zambia

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENDER; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SERVICE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RURAL HEALTH CARE; SCHOOL CHILD; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL; ZAMBIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COINFECTION; DEVELOPING COUNTRIES; FEMALE; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; MOBILE HEALTH UNITS; PROGRAM EVALUATION; REGISTRIES; RETROSPECTIVE STUDIES; RURAL HEALTH SERVICES; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT; ZAMBIA;

EID: 84875424287     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0432     Document Type: Article

References (27)

1. Central Statistical Office, Ministry of Health, Tropical Diseases Research Centre, University of Zambia and Macro International Inc. Zambia Demographic and Health Survey 2007. Lusaka, Zambia: CSO and Macro International Inc, 200-9.
2. World Health Organization. Global tuberculosis report: WHO report 2010. WHO/HTM/TB/2010.7. Geneva, Switzerland: WHO, 201-0.
3. Ministry of Health. National guidelines for HIV counselling and testing. Lusaka, Zambia: Ministry of Health, 201-0.
4. Ministry of Health and National AIDS Council. National mobile HIV services guidelines. Lusaka, Zambia: Ministry of Health, 200-9.
5. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359: 2059-206-4.
6. Cohen M S, Chen Y Q, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-50-5.
7. Hermans S M, Castelnuovo B, Katabira C, et al. Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda. J Acquir Immune Defic Syndr 2012; 60: e29-e3-5.
8. Vijay S, Kumar P, Chauhan L S, Rao S V, Vaidyanathan P. Treatment outcome and mortality at one and half year followup of HIV infected TB patients under TB control programme in a district of South India. PLoS ONE 2011; 6: e2100-8.
9. Varma J K, Nateniyom S, Akksilp S, et al. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis 2009; 9: 4-2.
10. World Health Organization. Treatment of tuberculosis guidelines. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 200-9.
11. Zachariah R, Harries A D, Srinath S, et al. Language in tuberculosis services: can we change to patient-centred terminology and stop the paradigm of blaming the patients? Int J Tuberc Lung Dis 2012; 16: 714-71-7.
12. Hung C C, Chen M Y, Hsiao C F, Hsieh S M, Sheng W H, Chang S C. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS 2003; 17: 2615-262-2.
13. Dheda K, Lampe F C, Johnson M A, Lipman M C. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004; 190: 1670-167-6.
14. Haar C H, Cobelens F G J, Kalisvaart N A, van Gerven P J H J, van der Have J J. HIV-related mortality among tuberculosis patients in the Netherlands, 1993-2001. Int J Tuberc Lung Dis 2007; 11: 1038-104-1.
15. Huerga H, Spillane H, Guerrero W, Odongo A, Varaine F. Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya. Int J Tuberc Lung Dis 2010; 14: 611-61-5.
16. Tansuphasawadikul S, Saito W, Kim J, et al. Outcomes in HIVinfected patients on antiretroviral therapy with tuberculosis. Southeast Asian J Trop Med Public Health 2007; 38: 1053-106-0.
17. Català L, Orcau A, García de Olalla P, Millet J-P, Rodríguez-Mondragón A, Caylà J A. Survival of a large cohort of HIVinfected tuberculosis patients in the era of highly active antiretroviral treatment. Int J Tuberc Lung Dis 2011; 15: 263-26-9.
18. Scott V, Chopra M, Azevedo V, Caldwell J, Naidoo P, Smuts B. Scaling up integration: development and results of a participatory assessment of HIV/TB services, South Africa. Health Res Policy Syst 2010; 8: 2-3.
19. Pfeiffer J, Montoya P, Baptista A J, et al. Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique-a case study. J Int AIDS Soc 2010; 13:-3.
20. Gasana M, Vandebriel G, Kabanda G, et al. Integrating tuberculosis and HIV care in rural Rwanda. Int J Tuberc Lung Dis 2008; 12 (Suppl 1): S39-S4-3.
21. Zachariah R, Spielmann M-P, Harries A D, Salaniponi F L. Voluntary counselling, HIV testing and sexual behaviour among patients with tuberculosis in a rural district of Malawi. Int J Tuberc Lung Dis 2003; 7: 65-7-1.
22. Laserson K F, Wells C D. Reaching the targets for tuberculosis control: the impact of HIV. Bull World Health Organ 2007; 85: 377-38-1.
23. Harries A D, Zachariah R, Lawn S D. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. Int J Tuberc Lung Dis 2009; 13: 6-1-6.
24. Nunn A J, Mwaba P, Chintu C, Mwinga A, Darbyshire J H, Zumla A. Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial. BMJ 2008; 337: a25-7.
25. Abdool Karim S S, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010; 362: 697-70-6.
26. Hirnschall G, Schwartlander B. Treatment 2.0: catalysing the next phase of scale-up. Lancet 2011; 378: 209-21-1.
27. Anglemyer A, Rutherford G W, Egger M, Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIVdiscordant couples. Cochrane Database Syst Rev 2011; 5: CD00915-3.